| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |